Defining the Population and Target Population in Clinical Studies: Clarifying Terminology and Enhancing Study Validity
Michael Mncedisi Willie
Council for Medical Schemes, Policy Research and Monitoring, Pretoria, South Africa
Michael Mncedisi Willie, Council for Medical Schemes, Policy Research and Monitoring, Pretoria, South Africa.
Accurate delineation of the population and target population is of utmost significance in clinical studies to ensure the conduction of research that is meaningful and applicable [1,2]. These terms serve as the foundation for study design, participant selection, data collection, and analysis . Understanding the distinction between population and target population allows researchers to precisely identify the group of individuals under investigation and tailor their interventions or treatments accordingly . This expanded discussion will delve into the definitions and importance of the population and target population in clinical studies, highlighting their roles in research design and the generation of evidence-based findings .
Defining the Population in Clinical Studies
Defining the population is a critical step in clinical research as it provides the framework for selecting participants and collecting data [4,5]. The population should be clearly defined to ensure that the study’s findings accurately represent and can be generalized to the broader population of interest [4,5]. By clearly defining the population, researchers can establish the boundaries and scope of their study, enabling them to draw meaningful conclusions and make valid inferences [4,5]. To define the population, researchers consider various factors such as demographic characteristics, clinical parameters, and specific research objectives . Demographic characteristics may include age, gender, ethnicity, socioeconomic status, and geographical location [4,6]. These characteristics help to establish the specific group of individuals within the larger population that the study will focus on. For instance, a study investigating the prevalence of hypertension in middle-aged adults may define the population as individuals between the ages of 40 and 60 years .
Clinical parameters are another important consideration when defining the population . These parameters may include specific health conditions, disease severity, treatment history, or other relevant clinical factors [2,8]. By incorporating clinical parameters, researchers can ensure that the population accurately represents the individuals who have the condition or attribute being studied [2,8]. For example, a study examining the impact of a new medication for diabetes may define the population as individuals diagnosed with type 2 diabetes and who have been on standard treatment for at least six months [9,10].
Furthermore, the specific research objectives guide the definition of the population . Researchers need to clearly articulate the research question or hypothesis they seek to address . This helps in narrowing down the population to individuals who are most relevant to the research objectives. For instance, a study investigating the effectiveness of a cognitive-behavioral therapy intervention for anxiety disorders may define the population as individuals diagnosed with generalized anxiety disorder or panic disorder . By clearly defining the population, researchers ensure that the study’s findings are applicable to the intended group and can be generalized to a broader population of interest . This process enhances the internal validity of the study, enabling researchers to draw meaningful conclusions and make accurate inferences about the target population. Examples of Population in Clinical Studies are as follows:
Examples of Population
- Type 2 Diabetes Patients: In a study investigating the effectiveness of a new medication for managing type 2 diabetes, the population would comprise individuals diagnosed with type 2 diabetes, irrespective of their age, gender, or other specific criteria related to the research question.
- Pregnant Women: In a study examining the impact of prenatal nutrition on fetal development, the population would consist of pregnant women at different stages of pregnancy, with no restrictions based on age, race, or socioeconomic status.
- Elderly Stroke Survivors: In a study exploring rehabilitation strategies for elderly stroke survivors, the population would include individuals aged 65 and above who have experienced a stroke and are undergoing rehabilitation.
- Cancer Patients Undergoing Chemotherapy: In a study investigating the side effects of chemotherapy, the population would encompass cancer patients of any type and stage who are currently receiving chemotherapy treatment.
- Healthcare Professionals: In a study examining the factors influencing clinical decision-making, the population would consist of healthcare professionals, such as physicians or nurses, working in a specific medical specialty or practice setting.
Defining the Target Population in Clinical Studies
The target population in clinical studies is a defined group of individuals or subjects who meet specific criteria for inclusion in the research [1-5]. Defining the target population requires careful consideration of various factors, including demographic characteristics, clinical parameters, and the specific research objectives [1-5]. This process ensures that the study’s findings are applicable to the intended recipients and can be used to inform decision-making and interventions in clinical practice. Demographic characteristics play a significant role in defining the target population [1-5]. Factors such as age, gender, ethnicity, socioeconomic status, and geographical location may be considered when determining the characteristics of the individuals who will be included in the study . For example, a study focusing on the efficacy of a new treatment for prostate cancer may specifically target men aged 50 to 70 years, as this age group represents the population most affected by the disease .
Clinical parameters are another essential consideration in defining the target population [1-4]. These parameters may include specific health conditions, disease severity, stage of illness, comorbidities, or treatment history. By defining the clinical parameters, researchers can ensure that the study’s findings are applicable to individuals with similar health profiles [1-4]. For instance, a study investigating the effectiveness of a medication for hypertension may target individuals diagnosed with stage 2 hypertension and without significant comorbidities to assess the medication’s impact in a specific clinical context .
Furthermore, the specific research objectives of the study play a critical role in defining the target population [1-5]. Researchers need to identify the specific outcomes they aim to measure or the hypotheses they intend to test. This information helps refine the criteria for participant selection and ensures that the target population aligns with the research goals [1-5]. For example, a study exploring the impact of a behavioral intervention on smoking cessation may target individuals who have expressed a desire to quit smoking but have experienced difficulty in doing so. By accurately defining the target population, researchers can tailor their interventions or treatments to meet the specific needs of the intended recipients [1-5]. This approach allows for the selection of appropriate participants who are more likely to benefit from the intervention and ensures that the study findings are directly applicable to the target population.
Moreover, the identification of the target population assists in generating findings that have practical implications in clinical practice [1-5]. By studying a specific population with defined characteristics, researchers can generate evidence that is relevant to healthcare providers, policymakers, and other stakeholders who work directly with the target population [1-5]. This targeted approach enhances the likelihood of translating research findings into meaningful interventions or strategies that can improve patient outcomes and address the specific needs of the population under study. Examples of Defined Target Populations are depicted as follows:
- Pregnant Women with Gestational Diabetes:
• Study Objective: To evaluate the effectiveness of a dietary intervention in managing gestational diabetes.
• Target Population: Pregnant women diagnosed with gestational diabetes, aged 18-40 years, without pre-existing diabetes or other major comorbidities.
- Elderly Stroke Survivors:
• Study Objective: To investigate the impact of a rehabilitation program on functional outcomes in elderly stroke survivors.
• Target Population: Individuals aged 65 and above, who have experienced a stroke within the past six months and have completed acute medical care.
- Adolescents with Major Depressive Disorder:
• Study Objective: To assess the efficacy of a new pharmacological intervention in treating major depressive disorder in adolescents.
• Target Population: Adolescents aged 12-17 years, diagnosed with major depressive disorder based on DSM-5 criteria, with moderate to severe symptomatology.
- Adults with Type 2 Diabetes and Obesity:
• Study Objective: To examine the effects of a lifestyle intervention on glycemic control and weight management in adults with type 2 diabetes and obesity.
• Target Population: Adults aged 30-65 years, diagnosed with type 2 diabetes and a body mass index (BMI) greater than or equal to 30 kg/m².
- Postmenopausal Women at Risk of Osteoporosis:
• Study Objective: To compare the efficacy of different pharmacological treatments in preventing osteoporotic fractures in postmenopausal women.
• Target Population: Postmenopausal women aged 50-75 years, with no prior history of osteoporotic fractures but with a high risk of developing osteoporosis based on bone mineral density measurements.
Defining the population and target population in clinical studies is a fundamental step for ensuring study validity and the meaningful interpretation of research findings. The process involves clarifying terminology and adopting a systematic approach to population definition, considering demographic characteristics, clinical parameters, and research objectives. Clear and consistent population definition enhances the accuracy and reliability of study results by establishing the boundaries and scope of the research. By precisely identifying the demographic characteristics, researchers can focus on specific groups within the larger population, making the findings more applicable to the intended recipients. Incorporating relevant clinical parameters ensures that the selected population accurately represents the individuals with the condition or attribute under investigation, enhancing the internal validity of the study. Research objectives guide the definition process, aligning the study population with the specific outcomes or hypotheses being tested.
To improve study validity, it is recommended that researchers adhere to a standardized approach when defining the population and target population. This includes clearly articulating the inclusion and exclusion criteria based on relevant demographic characteristics and clinical parameters. Consistency in terminology facilitates comparability and replication of study findings across different research settings. Researchers should also consider the potential impact of population selection on the external validity or generalizability of their findings. While it may be necessary to define a specific target population for focused research objectives, researchers should acknowledge the limitations and potential biases that may arise from such exclusions. Striking a balance between specificity and broader applicability of study results is crucial.
- Banerjee A, Chaudhury S (2010) Statistics without tears: Populations and samples. Industrial Psychiatry Journal 19: 60-65.
- Martínez-Mesa J, González-Chica DA, Duquia RP, Bonamigo RR, Bastos JL (2016) Sampling: How to select participants in my research study? Anais Brasileiros de Dermatologia 91: 326-330.
- Sutton J, Austin Z (2015) Qualitative Research: Data Collection, Analysis, and Management. The Canadian Journal of Hospital Pharmacy 68: 226-231.
- Casteel A, Bridier NL (2021) Describing populations and samples in doctoral student research. International Journal of Doctoral Studies 16: 339-362.
- Babbie ER (2010) The practice of social research. Belmont, CA: Wadsworth Publishing Company.
- Hatch SL, Frissa S, Verdecchia M, Stewart R, Fear NT, et al. (2011) Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study. BMC Public Health 11: 861.
- Lacruz ME, Kluttig A, Hartwig S, Löer M, Tiller D, et al. (2015) Prevalence and Incidence of Hypertension in the General Adult Population: Results of the CARLA-Cohort Study. Medicine 94: 952.
- Garg R (2016) Methodology for research I. Indian Journal of Anaesthesia 60: 640-645.
- Program Research Group DP (2002) Program Research Group DP (2002) Reduction in The Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. The New England journal of medicine 346: 393-403.
- Davies MJ, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. (2018) Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 41: 2669-2701.
- Tully MP (2014) Research: Articulating Questions, Generating Hypotheses, and Choosing Study Designs. The Canadian Journal of Hospital Pharmacy 67: 31-34.
- Kaczkurkin AN, Foa EB (2015) Cognitive-behavioral therapy for anxiety disorders: An update on the empirical evidence. Dialogues in Clinical Neuroscience 17: 337-346.
- Darin-Mattsson A, Fors S, Kåreholt I (2017) Different indicators of socioeconomic status and their relative importance as determinants of health in old age. Int J Equity Health 16: 173.
- Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA (2014) Prostate Cancer in Young Men: An Important Clinical Entity. Nature reviews. Urology 11: 317.
- Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, et al. (2020) Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. The Cochrane Database of Systematic Reviews 9: CD010315.